Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Severe Candida glabrata pancolitis and fatal Aspergillus fumigatus pulmonary infection in the setting of bone marrow aplasia after CD19-directed CAR T-cell therapy – a case report

(2021) Kai Rejeski et al.   BMC INFECTIOUS DISEASES

Condition de réalisation de la cytaphérèse pour la mise à disposition du matériel biologique nécessaire à la production de CAR T-cells commerciaux : avis d’experts proposé par la SFGM-TC

(2021) Sylvie Carnoy et al.   BULLETIN DU CANCER

Potential role of tocilizumab in severe gastrointestinal barrier damage after CAR T-cell therapy

(2021) David Beauvais et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR-T cell therapy

(2021) Binod Dhakal et al.   BLOOD

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

(2020) Jennifer M. Logue et al.   HAEMATOLOGICA

How we prevent infections in patients receiving CD19-targeted chimeric antigen receptor T-cells for B-cell malignancies

(2020) Joshua A. Hill et al.   BLOOD

G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma

(2020) Eugenio Galli et al.   BONE MARROW TRANSPLANTATION

Clinical data, limitations and perspectives on chimeric antigen receptor T-cell therapy in multiple myeloma

(2020) David Beauvais et al.   CURRENT OPINION IN ONCOLOGY

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

(2020) Kitsada Wudhikarn et al.   Blood Cancer Journal

CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges

(2020) Yongxian Hu et al.   Current Research in Translational Medicine

DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality

(2020) Kitsada Wudhikarn et al.   Blood Advances

Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper

(2020) Ibai Los-Arcos et al.   INFECTION

An international survey on the management of patients receiving CAR T-cell therapy for haematological malignancies on behalf of the Chronic Malignancies Working Party of EBMT

(2019) P.J. Hayden et al.   Current Research in Translational Medicine

Invasive Mold Infections After Chimeric Antigen Receptor–Modified T-cell Therapy: A Case Series, Review of the Literature, and Implications for Prophylaxis

(2019) Ghady Haidar et al.   CLINICAL INFECTIOUS DISEASES

Management of adults and children undergoing CAR t-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

(2019) Ibrahim Yakoub-Agha et al.   HAEMATOLOGICA

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

(2018) Shannon L. Maude et al.   NEW ENGLAND JOURNAL OF MEDICINE

Beginning the CAR T cell therapy revolution in the US and EU

(2018) Stephan Grupp   Current Research in Translational Medicine

Clinical Utilization of Chimeric Antigen Receptors T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation

(2018) Ankit J. Kansagra et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

(2018) Frederick L Locke et al.   LANCET ONCOLOGY

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

(2018) Stephen J. Schuster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

(2017) Sattva S. Neelapu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives

(2017) J. Gauthier et al.   Current Research in Translational Medicine

Ateliers d’harmonisation des pratiques de la SFGM-TC

(2016) Rachel Tipton et al.   BULLETIN DU CANCER